6 research outputs found
Univariate and multivariate analyses to assess associations with rifampicin resistance among all, previously treated, and HIV positive culture positive TB cases.
<p>Univariate and multivariate analyses to assess associations with rifampicin resistance among all, previously treated, and HIV positive culture positive TB cases.</p
Prevalence of drug resistance using line probe assay (LPA) results, conventional culture-based DST and combined among new and previously treated culture-positive TB cases.
<p>Prevalence of drug resistance using line probe assay (LPA) results, conventional culture-based DST and combined among new and previously treated culture-positive TB cases.</p
Resistance profile (first and second-line) for all MDR-TB cases (abbreviations: H = isoniazid, R = rifampicin, E = ethambutol, S = streptomycin, Z = pyrazinamide, Eto = ethionamide, Amk = amikacin, Km = kanamycin, Cm = capreomycin, Ofx = of
<p>Resistance profile (first and second-line) for all MDR-TB cases (abbreviations: H = isoniazid, R = rifampicin, E = ethambutol, S = streptomycin, Z = pyrazinamide, Eto = ethionamide, Amk = amikacin, Km = kanamycin, Cm = capreomycin, Ofx = ofloxacin).</p
Estimating the burden of rifampicin resistant tuberculosis in Khayelitsha.
<p>Estimating the burden of rifampicin resistant tuberculosis in Khayelitsha.</p
Second-line resistance among strains not defined as MDR-TB.
<p>Second-line resistance among strains not defined as MDR-TB.</p
Additional file 2: of The use of digital PCR to improve the application of quantitative molecular diagnostic methods for tuberculosis
Protocol for gDNA extraction and dPCR quantification of materials. (PDF 394 kb